The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Study

OBJECTIVE: To evaluate the effect of a pretreatment geriatric assessment on the clinical outcomes in older patients with unresectable or recurrent pancreatic ductal adenocarcinoma (PDAC) scheduled to receive gemcitabine (GEM)/GEM+nab-paclitaxel (GnP). PATIENTS: Older patients with unresectable PDAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Hiroshi, Nakazawa, Junichi, Nagashima, Fumio, Andou, Masahiko, Furuse, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292986/
https://www.ncbi.nlm.nih.gov/pubmed/36223928
http://dx.doi.org/10.2169/internalmedicine.9689-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292986/
https://www.ncbi.nlm.nih.gov/pubmed/36223928
http://dx.doi.org/10.2169/internalmedicine.9689-22

Ejemplares similares